During the acute liver injury, immune responses are provoked into eliciting inflammation in the acute phase. In the healing phase, the inflammation is terminated for wound healing and restoration of immune homeostasis. In this study, we sought to address how regulatory T cells (Tregs) are involved in the progression of liver injury and repair. In the acute phase, intrahepatic Tregs (CD4
Introduction
The liver, in contrast to other organs, is maintained in an immune-privileged state that is characterized by oral tolerance, acceptance of allograft, hepatic viral persistence, and high incidence of tumor metastasis (Tiegs and Lohse, 2010) . Immune privilege and tolerance are maintained through a myriad of mechanisms, including central tolerance to eliminate lymphocytes against self, and peripheral tolerance to restrain leaked and excessive immune response. The immune homeostasis sustained by dominant-negative regulation from immune regulatory cell, in particular CD4 + CD25 + Foxp3 + regulatory T cells (Tregs), over effector cells is of special importance for peripheral immune tolerance (Sakaguchi et al., 1995; Rudensky et al., 2006; Horwitz et al., 2008) . The suppressive functions of Tregs are largely mediated by forkhead box P3 (Foxp3), a master transcription factor that interacts with multiple co-transcriptional regulators to determine immune suppression (Hori et al., 2003) . In humans and murine models, defects in Foxp3 signaling cause a variety of autoimmune disorders (Roncarolo and Levings, 2000) . Notably, Tregs are downregulated upon infection or tissue injury, leading to acute inflammation. Conversely, excessive Tregs are often found with prolonged inflammation in chronically infected tissues, or loss of immune surveillance in the tumor microenvironment and tissue fibrosis (Ormandy et al., 2005; Yang et al., 2006; Liu et al., 2010; Zhou et al., 2010a) , suggesting that chronic inflammation may exempt fibroplasia and neoplasia from clearance (Zou, 2006) . In addition to thymus-derived and naturally occurring Tregs (nTregs), induced Tregs (iTregs) can be generated from CD25-negative precursors in vivo and ex vivo through TCR engagement together with interleukin-2 (IL-2) and transforming growth factor-beta (TGF-b) treatment (Zheng et al., 2002; Horwitz et al., 2008) . These two subsets share many key features, including expression of Foxp3, high expression of CD25 and CTLA-4, TCR signaling, and co-stimulation (Bilate and Lafaille, 2012) . However, they may exhibit distinct functions in immune responses. Under the pro-inflammatory conditions such as IL-6, nTregs can be further polarized to Th17 cells for immune aggression and autoimmunity (Mangan et al., 2006; Veldhoen et al., 2006) , while peripheral iTregs are resistant to IL-6-induced polarization, implying their potential to retain suppressive function in the inflammatory storm (Zheng et al., 2008) . Moreover, a recent work has shown that Helios, a member of the Ikaros transcription factor family, can be used as a marker to discriminate nTregs from iTregs (Thornton et al., 2010) .
Upon injury, the liver is able to rapidly switch from a normal network of immune privilege to immune aggression during the acute phase, and the elevated inflammation can be resolved during the late phase of wound healing, thus allowing wound closure and leading to restoration of immune privilege in the regenerated or healed liver.
Hepatic stellate cells (HSCs) are the majority of mesenchymal cells in the liver (Friedman, 2008) . Physiologically, HSCs constitute the basement membrane and extracellular matrix (ECM) that mechanically and biochemically support sinusoidal architecture and store large amount of retinoid lipids to maintain systemic retinoid homeostasis. In liver injury, HSCs undergo a line of marked responses, such as matrix metalloproteinase (MMP) cascade and retinoid mobilization, for wound healing (Han et al., 2004 (Han et al., , 2007 Kida et al., 2011) . TGF-b is the major cytokine that mediates immune suppression in wound healing and can be produced by stellate cells as well as other hepatic cells. The latent TGF-b deposited in the ECM network of the space of Disse can be cleaved into an active form in an MMP-dependent manner. The active TGF-b, in concert with all-trans retinoic acid (RA), can directly induce peripheral naive CD4
+ cells into functional iTregs (CD4 + CD25 + Foxp3 + ) (Zheng et al., 2002; Lu et al., 2010) . Thus, it is conceivable that the generation of iTregs in the liver wound healing is orchestrated in part by HSCs through two parallel pathways, namely MMPdependent activation of latent TGF-b and retinol/RA pathway.
Results

Rapid inflammation and liver injury in the acute phase is associated with loss of intrahepatic nTregs
We hypothesized that loss of nTregs in the acute phase is critical for initiation of inflammation, which consequently switches immune privilege into immune aggression to cope with tissue injury or infection. In order to identify Foxp3 + Tregs during the liver injury, transgenic Foxp3 GFP mice, in which an eGFP gene is inserted into the murine foxp3 locus, were challenged with a sublethal dose (0.2 mg/g body weight) of TAA. Massive parenchymal necrosis and hemorrhage, as indicated by H&E staining, became obvious within a few hours ( Figure 1A ). MMP9 was promptly expressed in the parenchymal liver and peripheral blood cells ( Figure 1B) , indicating a deep liver injury by the hepatic toxin (Yan et al., 2008) . Physiologically, Tregs (CD4 + Foxp3 GFP+ ) represented a relatively small population (2%-4%) of mononuclear cells (MNC) in the spleen, blood, and liver ( Figure 1C ). Upon toxin exposure, a decline of Tregs was observed within 3 h. Hepatic Tregs rapidly diminished to half within 6 h, while splenic and peripheral Tregs moderately declined ( Figure 1C ), indicating that TAA-induced reduction of Tregs occurred mostly in the liver. As shown in Figure 1D , the percentage of Foxp3 + cells among CD4 + subsets in both liver and peripheral blood (7%-10% in the normal mice) significantly decreased after TAA injection, while no significant change was observed in the lymph nodes and before 12 h in the spleen. Figure 1E) . Thus, the diminishment of nTregs synchronizes with the loss of immune privilege and a rapid initiation of inflammation in the acute phase. Apoptosis and regeneration of Tregs following TAA administration Apoptosis of nTregs during TAA-induced liver injury was first monitored in C57/B6 mice by double immunofluorescent staining for Foxp3 and active/mature caspase-3. C57/B6 mice were given a sub-lethal dose of TAA. As shown in Figure 2A, declined, indicating the transition from acute injury to wound healing. In the spleen, a similar but more profound phenomenon was observed, which might be attributed to the higher occurrence of Tregs in the spleen than in the liver. Importantly, apoptosis of Tregs in the acute phase also synchronizes with the loss of nTregs that switches immune privilege into inflammation. Likewise, the generation of iTregs in the later phase may be related to the termination of inflammation and initiation of wound healing.
Restoration of Tregs in the healing phase is critical for resolving inflammation Given the tight association between the loss of nTregs and onset of inflammation in the acute phase, we further hypothesized that a converse case, namely restoration of hepatic Tregs, might alleviate or terminate ongoing inflammation in the healing phase. As shown in Figure 3A , the damaged parenchymal tissue was mostly recovered at 72 h after toxin exposure, which correlated with declined MMPs ( Figure 3B ) and inflammatory cytokines ( Figure 3C ) that coincided with the healing (Gieling et al., 2009) . We then investigated de novo expression of hepatic Foxp3 mRNA during TAA-induced liver injury. As expected, Foxp3 mRNA level was promptly downregulated in the acute phase (within 12 h), increased to the peak at 24 h, and then returned to the basal level when the liver was healed ( Figure 3D ). Moreover, after the reduction in the acute phase, Tregs (CD4 + CD25 + Foxp3 GFP+ ) gradually increased in the healing phase, starting from 48 h post-injury and reaching the full scale after 72 h ( Figure 3E ). Since the thymus-derived nTregs could be distinguished from peripheral iTregs by the expression of Helios, a member of the Ikaros transcription factor family (Thornton et al., 2010) , we then measured Helios expression by FACS analysis in the subsets of CD4 + Foxp3 + cells. As shown in Figure 4A and B, 75% of Foxp3 GFP+ cells in the normal liver were Helios + . In contrast,
Foxp3
GFP+ cells in the healed liver (72 h) were largely devoid of Helios expression, and were thus designated as a CD4
To confirm the notion of iTreg generation during the liver wound healing, we performed an adoptive transfusion experiment by transferring naïve CD4 + GFP 2 T cells isolated from the spleen of Foxp3 GFP knock-in mice to receipt mice at 24 h after TAA challenge or saline as the control. Regeneration of Foxp3 GFP+ cells in the recipient liver was measured at 72 h postinjury. As shown in Figure 4C , the injury-healing process enhanced the generation of Foxp3 + cells by 60%, the percentage of Foxp3 GFP+ cells increasing from 3.3% in the control liver to 5.7%
in the healed liver. Taken together, these results suggest that at least a portion of Helios 2 Tregs in the liver are generated during the healing process. 
TGF-b-dependent induction of intrahepatic Tregs during liver wound healing
It has been shown that TGF-b is indispensible for proper wound healing, and that loss of TGF-b is related to excessive inflammation and autoimmunity (Lemire et al., 1995) . Previous studies have demonstrated that TGF-b can induce functional Tregs
in vitro and in autoimmune disease models (Namba et al., 2002; Zheng et al., 2004a) . In this study, active TGF-b in the liver was readily increased after liver injury and peaked at 24 h when the percentage of CD4 + Foxp3 + cells among hepatic MNC dropped to the lowest level ( Figure 5A ). Moreover, the dynamics of active TGF-b during liver injury and repair coincided with that of Foxp3 mRNA expression ( Figure 3D ), suggesting a potential causative relationship between TGF-b and the induction of Foxp3 + cells during wound healing. Then, transgenic mice lacking TGF-b signaling in CD4 + cells through expressing a dominant-negative TGFbRII driven by a CD4 promoter (dnTGFbRII/CD4) (Gorelik and Flavell, 2000) were compared with wild-type (WT) mice during TAA-induced liver injury. Three days after toxin exposure (healing phase), dnTGFbRII/CD4 mice exhibited persistent tissue damage and high MMP9 activity without wound healing, while WT mice showed declined MMP9 level along with proper wound healing and regeneration of parenchyma ( Figure 5B and C), which suggests the involvement of TGF-b signaling in the liver wound healing. Accordingly, a restoration of hepatic Tregs was observed after 3 days in TAA-treated WT mice, but this was profoundly abrogated in dnTGFbRII mice ( Figure 5D , 10.6% vs. 0.35% of CD25 + Foxp3 + among CD4 + cells), demonstrating a critical role of TGF-b signaling in the induction of Tregs. Importantly, dnTGFbRII expression did not significantly change the nTregs level in mice without TAA challenge ( Figure 5E ), indicating that TGF-b signaling participates primarily in the induction of iTregs during wound healing rather than nTregs derived from thymus.
MMP-dependent activation of latent TGF-b in the induction of Tregs during wound healing
Hepatic TGF-b, in its latent form, can be produced by HSCs and stored in the ECM repertoire of the space of Disse (Friedman et al., 2008) . Thus, MMPs produced by HSCs in this space might facilitate the release of active form of TGF-b that consequently induced iTreg during wound healing. In this study, multiple MMPs, in particular MMP9 and MMP13, significantly increased the expression at 4-12 h after liver injury ( Figure 6A) . At 24 h after liver injury, active/diffusible TGF-b level was significantly elevated in the liver of WT mice ( 600 pg/100 mg liver tissue), which was notably impaired in both MMP9 2/2 (300 pg/100 mg liver tissue) and MMP13 2/2 (200 pg/100 mg liver tissue) mice ( Figure 6B ).
Alpha-smooth muscle actin (a-SMA), the important downstream target of TGF-b signaling, was upregulated in the liver of WT mice at 72 h after injury, but was not significantly altered in MMP9
2/2 and MMP13 2/2 mice. As shown in Figure 6D , activated stellate cells with a-SMA expression were evident around the portal vein in WT mice at 72 h after injury, while such HSC activation was remarkably attenuated in MMP9 2/2 and MMP13 2/2 mice, implying a defective TGF-b signaling during liver wound healing in these knockout mice. Meanwhile, hepatic Tregs, as detected by Foxp3 staining, were fully restored in the liver of WT mice in a manner Figure 6E ). Taken together, these results suggest a potential mechanism of MMP-dependent activation of latent TGF-b that promotes the generation of iTregs for liver wound healing.
Depletion of Tregs impedes resolving inflammation and delays wound healing
To examine whether Tregs induction is necessary for resolving inflammation during wound healing, mice were treated with PC61, a neutralizing monoclonal antibody against CD25, or isotype IgG as a control at 24 h after TAA injection. After an additional 48-h, mice were euthanized for further examination ( Figure 7A ). PC61 treatment led to a substantial depletion of Tregs (CD4 + Foxp3 + ) in the lymph nodes, spleen, peripheral blood, and liver ( Figure 7B) . At 72 h post toxin exposure, in contrast to a complete wound healing in the control mice ( Figures 3 and 7C and D) , depletion of Tregs leads to an escalated and persistent tissue injury without alleviation, as marked by elevated plasma ALT level ( Figure 7C ), liver hemorrhage and necrosis ( Figure 7D ), sustained inflammatory cytokines IL-1b and IL-6 ( Figure 7F ), and high MMP9 activity (data not shown Figure 7E ). Taken together, these results demonstrate that regenerated Tregs play a key role in resolving inflammation during liver wound healing in the healing phase.
Discussion
The evidence presented in this study supports our hypothesis that loss of nTregs, featured by CD4 + Foxp3 + Helios + , may mediate inflammation in the acute phase, while iTregs, characterized by CD4 + Foxp3 + Helios 2 , are generated in the liver during the healing phase to alleviate ongoing inflammation. In particular, our results delineate a novel molecular mechanism by which MMP9/13-dependent activation of the TGF-b cascade induces iTregs to resolve inflammation during wound healing. groups and the control. *P , 0.05, **P , 0.01.
Tregs in liver injury and repair
To investigate how immune privilege is collapsed in the acute phase, we first analyzed the changing course of Tregs in the liver. We noticed that nTregs were promptly diminished, which coincided with the burst of inflammation and tissue injury. Moreover, the residential nTregs underwent apoptosis, which may well explain how Tregs decline to license the acute inflammation. However, exact mechanisms underlying the apoptosis of nTregs in the acute phase remain elusive, although many pro-apoptotic and pathophysiological factors have been found in the injured liver. For instance, elevated inflammatory cytokines, MMPs, FasL, and bacterial components may directly trigger apoptosis of Tregs. In addition, it was shown that depleting Tregs could exacerbate Con-A-induced fulminating hepatitis, whereas adoptive transfusion of Tregs alleviates liver injury (Wei et al., 2008) . Different from Con-A that induces T cell activation, we found that a variety of hepatocyte toxins can downregulate Tregs through apoptosis, resulting in innate immunity. In a model of Kupffer cell-mediated fulminating hepatitis that was triggered by lipopolysaccharide plus D-galactosamine, we found prompt apoptosis of Tregs (unpublished data), demonstrating that downregulation of Tregs might be a common pathway triggering either innate or adaptive immunity during the acute injury phase. Importantly, Tregs were also diminished in the peripheral blood and spleen but not changed in the lymph nodes during the acute phase, the outflow of hepatic Tregs into circulation or other organs is not a likely scenario. Thus, apoptosis of nTregs is responsible for the loss of hepatic nTregs in the acute phase.
The CD4 + Foxp3 + Helios + cells were designated as nTregs, while the CD4 + Foxp3 + Helios 2 cells were regarded as peripheral iTregs (Thornton et al., 2010; Akimova et al., 2011) . In agreement with this notion, Foxp3 + Helios + nTregs in the liver healing phase were much less than those in the normal liver, while Foxp3 + Helios 2 iTregs were conversely increased during wound healing, indicating that iTregs were a predominant subset in the healing phase ( Figure 4) . Furthermore, TGF-b activation and iTreg induction were retarded in MMP9 2/2 and MMP13 2/2 mice (Figure 6 ), indicating that the induction of iTregs relies on the MMP-dependent activation of TGF-b. Such notion was additionally demonstrated by using mice conditionally defective of TGF-b signaling in CD4 T cells ( Figure 5 ). Our previous work explicitly showed that MMPs are induced by pro-inflammatory cytokines such as IL-1a and TNF-a during the injury phase (Han et al., 2004) . Thus, the transition from injury into wound healing can be orchestrated by injury signals such as IL-1 that triggers MMP-TGF-b signaling to induce Foxp3 in the naïve CD4 + cells, which consequently terminate the ongoing inflammation.
HSCs may contribute to iTreg induction through two parallel pathways that converge at the point of Foxp3 induction. First, HSCs are major repositories of retinoids in the body. Upon injury signals, retinoids can be mobilized and then oxidized to all-trans RA, a key component to sustain Foxp3 expression (Zhou et al., 2010b) . Moreover, iTregs induced by retinoid acid are devoid of Th17 polarization (Xiao et al., 2008; Lu et al., 2010) . Such scenario is supported by recent reports showing that although HSCs could not directly induce Foxp3 and Tregs, the RA produced by these cells was able to sustain iTregs induction (Ichikawa et al., 2011; Dunham et al., 2013) . We also showed that the injury signal IL-1 is able to mobilize retinoid esters stored as droplets in the HSCs (Kida et al., 2011) . Second, HSCs may promote iTreg generation through TGF-b signaling. We have reported that in response to IL-1a, HSCs produced large amount of MMPs adjacent to the latent TGF-b complex inside the space of Disse (Gieling et al., 2009) . Accordingly, in an in vitro system mimicking the microenvironment in the space of Disse, HSCs embedded in ECM generated active and diffusible TGF-b in an MMP-dependent manner when stimulated by IL-1a (Han et al., 2007) . A temporal association among MMP expression, latent TGF-b activation, and regeneration of Tregs in liver wound healing is outlined in this study. After liver injury, MMP9 and MMP13 are upregulated within 4 -12 h, followed by TGF-b activation after 24 h, which is coincident with intrahepatic expression of Foxp3 and induction of iTregs (CD4 + Foxp3 + Helios 2 ) within 24-36 h. These events were impaired in mice lacking MMPs or TGF-b signaling, confirming the pathway culminating with the regeneration of Tregs in liver wound healing, which starts from MMP9/13 expression to promote TGF-b activation that results in Foxp3 expression.
Naïve CD4 + cells under TGF-b signal and TCR activation can upregulate Foxp3 and CD25, resulting in phenotypical Tregs for immune suppression (Chen et al., 2003; Zheng et al., 2004b) . Pro-inflammatory cytokines such as IL-6, TNF-a, and IFN-g may potentially skew Tregs towards other subsets, such as Th17 (Mangan et al., 2006; Veldhoen et al., 2006) . It has been shown that in the presence of both TGF-b and IL-6, naïve T cells can be converted to Th17 cells via RORgt (Ivanov et al., 2006) . During the transition, the Foxp3 + RORgt + intermediates are suggested to be eventually reprogrammed to a Th17 phenotype (Lochner et al., 2008; Yang et al., 2008) . Based on the fact that RA can prevent Th17 generation in the presence of inflammatory stimulation (Xiao et al., 2008; Wang et al., 2010) , it is highly conceivable that the abundance of retinoid sources in HSCs may contribute to hepatic iTreg induction. Taken together, we propose a pathophysiological cascade governing the transition from liver injury to wound healing ( Figure 7G ). First, loss of nTregs through apoptosis in the acute phase may license the liver into innate immunity outburst, which is initiated by damaged epithelial cells and followed by activation of KC and NK cells. Then, IL-1 generated in the acute phase may serve as an injury signal to mobilize the quiescent HSCs, resulting in MMP cascade and consequent TGF-b activation. IL-1 can also downregulate lecithine retinol acyltransferase in the quiescent HSCs, leading to mobilization of retinoid, which can be readily oxidized to RA. Consequently, TGF-b and RA in the sinusoids produced by HSCs may induce Foxp3 expression in a syngeneic way occurring in the CD4 + cells, through which the naïve CD4 T cells are converted to iTregs, which ultimately terminate inflammation for wound healing. Whether nTregs and iTregs share similar mechanisms or not for immune regulation in different tissue environments requires further determination (Horwitz et al., 2008) .
Materials and methods
Animals and treatment MMP9KO (FVB) mice obtained from Jackson Laboratory and MMP13KO (FVB) mice provided by Dr Zena Werb at UCSF were crossed into C57/B6 for eight generations, respectively. The homozygous WT male mice were used as control. Foxp3
GFP knock-in (C57/B6) mice were provided by Dr Talil Chatilla at UCLA. Transgenic mice designated as dnTGFbRII/CD4 for a dominantnegative TGF-b receptor signaling driven by a CD4 promoter were previously described (Gorelik and Flavell, 2000) . PC61, a monoclonal neutralizing antibody against CD25, was obtained from ATCC and applied for the depletion of Tregs. Acute liver injury was induced by intraperitoneal injection of thioacetamide (TAA) at the dose of 0.2 mg/g body weight. Same amount of saline was injected as control. The mice were sacrificed at the indicated time points. All protocols were in compliance with the Institutional Animal Care and Use Committee at the University of Southern California. Cell preparation and flow cytometry Liver tissues were minced through a cell-strainer (70-mm) in RPMI1640 medium containing 2% fetal bovine serum (FBS). After centrifugation at 2000 rpm for 10 min, the supernatant was discarded. The pellets were then suspended in 3 ml RPMI1640 containing 100 ml type-I collagenase (200 U/ml, Wortington) and 5 ml DNase I (50 -100 U/ml, Sigma) for digestion by shaking at 160 rpm at 378C for 40 min. Cells were collected and washed by passing through a cell-strainer and then suspended in 20 ml RPMI1640 and loaded on top of 10 ml Ficoll-paque in 50-ml tubes. After centrifugation at 3000 rpm at 48C for 30 min, the opaque middle layer was collected and washed.
Peripheral blood mononuclear cells (PBMC) were prepared by dilution in PBS with heparin, followed by ammonia chloride lysis treatment (Sigma Aldrich). Splenic MNC were prepared by mincing the spleen through a cell-strainer, followed by washing and ammonia chloride lysis treatment. All cells were washed by RPMI1640 with 2% FBS and cell numbers were counted.
For surface staining, 1 × 10 5 -5 × 10 5 cells were incubated with PE-conjugated rat anti-mouse CD25, NK1.1, F4/80, or Gr-1 (Biolegend) and/or Cy5-conjugated rat anti-mouse CD4 or CD8 (Biolegend) at 48C for 20 min. To determine the nuclear Foxp3 and Helios, cells after the surface staining were treated with fixation buffer (Biolegend), followed by Perm buffer at 48C for 1 h and then incubated with FITC-conjugated rat anti-mouse Foxp3 and PE-conjugated hamster anti-mouse Helios (Biolegend) at 48C for 30 min.
To in the liver wound healing was demonstrated by FACS analysis.
Immunofluorescence staining
Immunofluorescence was performed essentially as previously described (Qin and Han, 2011) . Briefly, liver section slides in OCT were fixed with ice-cold methanol followed by permeabilization with 0.1% Triton X-100 in PBS for 10 min. After blocking with 5% donkey serum or non-fat milk in PBS, specimens were incubated with polyclonal antibodies against mature/processed active caspase-3 (R&D Systems), followed by incubation with FITC-conjugated goat anti-rabbit IgG and PE-conjugated rat antimouse Foxp3 (Biolegend). Cells were subjected of counter staining by DAPI and examined by Nikon Eclipse TE2000 microscopy.
Zymography analysis
Zymography was performed as described previously (Han et al., 2007) . In brief, 100 mg liver tissues were homogenized in 1 ml homogenization buffer (100 mM NaCl, 50 mM Tris-HCl, pH7.4, and 1% Triton X-100). After centrifugation at 15000 rpm for 10 min, the supernatant was collected. Gelatinases were pulled down by gelatin-conjugated Sepharose 4B beads (GE Health Science) following standard procedures.
Quantitative RT-PCR analysis
Total RNA was extracted from liver tissue using TRIZOL (Life Technologies) and first-strand cDNA was synthesized using SuperScript II Reverse Transcriptase (Promega) according to manufacturer's instructions. The products were diluted 10 times with pure water. Q-PCR was carried out in ABI Prism 7900HT (Applied Biosystems) using SYBR Green master mix (Eurogentec) according to manufacturer's instructions. PCR conditions included one activation step (958C for 10 min), 40 amplification cycles (958C for 15 sec, 608C for 1 min), and quantification with a single fluorescence measurement. Primer sequences used for PCR amplification of mouse genes are as follow: IL-1a, 5 ′ -CACAACTGTTCGTGAGCGCT- 
TGF-b activity assay
Liver tissues (100 mg) were homogenized in 1 ml buffer (100 mM NaCl and 50 mM Tris) supplemented with a proteinase inhibitor cocktail. After mild homogenization, supernatants were obtained by centrifugation at 10000× g for 15 min at 48C. Active TGF-b 1 in the extract was quantitatively determined by ELISA (R&D System) according to manufacturer's instruction.
Western blot analysis
Liver tissues (100 mg) were homogenized in 1 ml sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 10% Glycerol, 0.0025% Bromophenol Blue, and 0.1 M DTT). After boiling for 8 min, lysates were centrifuged at 15000 rpm for 10 min and supernatants were collected. Proteins were resolved by SDS-PAGE and transferred to PVDF membranes. Membranes were blocked for 3 h in 5% non-fat milk, and hybridized to polyclonal anti-a-SMA (LabVision) and monoclonal anti-GAPDH (Cell Signaling Technology) and then horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) for subsequent detection by Super Signal West Femto Chemiluminescent substrate (Pierce).
Statistical analysis
Results are expressed as mean + SEM. The differences between two groups were analyzed using two-tailed Student's t-test.
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